AlphaYouSC
Schedule 13G filing
Streeterville Capital LLC cut its Vivos Therapeutics, Inc. (VVOS) stake below 5%
Streeterville Capital LLC reported owning 0.6% of Vivos Therapeutics, Inc. (VVOS) (122,963 shares) in a Schedule 13G filed Sep 3, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 3, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.